LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer

Pancreatic cancer is the fourth leading cause of cancer death in the United States. The main methods of treating pancreatic cancer are surgery and chemotherapy, but the treatment efficacy is low with a poor prognosis. Immunotherapy represented by PD-1/PD-L1 has brought a milestone progress in the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zhengwei, Wang, Xiaoguang, Chen, Fei, Chen, Qiuli, Liu, Wenjun, Yang, Xiaodan, Zhu, Xun, Liu, Xiaorong, Wang, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533337/
https://www.ncbi.nlm.nih.gov/pubmed/36212476
http://dx.doi.org/10.3389/fonc.2022.1004212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533337/
https://www.ncbi.nlm.nih.gov/pubmed/36212476
http://dx.doi.org/10.3389/fonc.2022.1004212

Ejemplares similares